83 related articles for article (PubMed ID: 347879)
1. Preliminary note on the antipsychotic efficacy of bromperidol.
Bataille M
Acta Psychiatr Belg; 1978; 78(1):173-9. PubMed ID: 347879
[TBL] [Abstract][Full Text] [Related]
2. Double-blind- evaluation of bromperidol versus haloperidol treatment in chronic psychotic patients.
Malfroid M; Hens L; Roosen P; Dom R
Acta Psychiatr Belg; 1978; 78(1):147-54. PubMed ID: 347877
[TBL] [Abstract][Full Text] [Related]
3. [Clinical experience with bromperidol in chronic psychoses].
Bellomo LE; Rosset N; Tellarini L; Forconesi N
Acta Psiquiatr Psicol Am Lat; 1988 Sep; 34(3):230-6. PubMed ID: 3071092
[TBL] [Abstract][Full Text] [Related]
4. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.
Woggon B
Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878
[TBL] [Abstract][Full Text] [Related]
5. [Treatment with bromperidol in schizophrenic patients].
Ellerman LA
Acta Psiquiatr Psicol Am Lat; 1988 Dec; 34(4):335-40. PubMed ID: 2908218
[TBL] [Abstract][Full Text] [Related]
6. [Treatment with bromperidol in schizophrenic patients].
Ellerman LA
Acta Psiquiatr Psicol Am Lat; 1989; 35(1-2):23-30. PubMed ID: 2634329
[TBL] [Abstract][Full Text] [Related]
7. Results of a clinical trial with bromperidol C-C 2489/21.
Weiser G
Acta Psychiatr Belg; 1978; 78(1):102-9. PubMed ID: 347873
[TBL] [Abstract][Full Text] [Related]
8. Use of bormperidol in psychotic outpatients.
Clarysse HJ
Acta Psychiatr Belg; 1978; 78(1):129-33. PubMed ID: 347875
[TBL] [Abstract][Full Text] [Related]
9. The initial US clinical experience in the management of schizophrenic patients with bromperidol.
Gardner E
Acta Psychiatr Belg; 1978; 78(1):134-46. PubMed ID: 347876
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial with bromperidol in psychotic states.
Brasseur R
Acta Psychiatr Belg; 1978; 78(1):110-7. PubMed ID: 645404
[TBL] [Abstract][Full Text] [Related]
11. [Bromperidol decanoate in the residual phase of schizophrenia].
Smeraldi E; Cocconcelli C; Canova L; Faravelli C; Marchetti FP; Mariani G; Rapisarda V
Minerva Psichiatr; 1996 Mar; 37(1):39-44. PubMed ID: 8926856
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the efficacy of haloperidol decanoate].
Alvarez JV; Li Gambi M
Acta Psiquiatr Psicol Am Lat; 1986 Sep; 32(3):233-6. PubMed ID: 2884807
[TBL] [Abstract][Full Text] [Related]
13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
14. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of effectiveness and tolerance of the long-term treatment with bromoperidol decanoate in psychotic disorders].
Levi Minzi A; Laviani M
Minerva Psichiatr; 1992; 33(1):51-5. PubMed ID: 1406161
[TBL] [Abstract][Full Text] [Related]
16. [Chronic treatment of schizophrenia with injectable bromperidol decanoate].
Suárez Richards M
Acta Psiquiatr Psicol Am Lat; 1985 Sep; 31(3):222-8. PubMed ID: 2870608
[TBL] [Abstract][Full Text] [Related]
17. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
Ehmann TS; Delva NJ; Beninger RJ
J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
[TBL] [Abstract][Full Text] [Related]
18. Treatment of female schizophrenic patients with bromperidol, a new neuroleptic drug of the butyrophenone group with medium duration of action.
Fleischhauer J
Acta Psychiatr Belg; 1978; 78(1):118-28. PubMed ID: 347874
[TBL] [Abstract][Full Text] [Related]
19. Open study with bromperidol in hospitalized chronic schizophrenic patients.
Hermans W
Acta Psychiatr Belg; 1978; 78(1):89-95. PubMed ID: 347883
[TBL] [Abstract][Full Text] [Related]
20. Bromperidol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in psychoses.
Benfield P; Ward A; Clark BG; Jue SG
Drugs; 1988 Jun; 35(6):670-84. PubMed ID: 3048975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
